Perfusion Medical is an emerging biopharmaceutical company developing life-saving, acute cardiovascular therapies to transform critical care medicine, with a focus on shock and ischemic conditions. The company’s lead candidate, PM-208, is designed to rapidly restore microvascular perfusion, resolving ischemia and protecting vital organs. Preclinical data suggest that PM-208 has the potential to improve survival outcomes, accelerate patient recovery, and reduce long-term comorbidities in conditions such as hemorrhagic shock, cardiogenic shock, and acute kidney injury.

Perfusion Medical

Org chart

Teams

Offices